Technologies

Technical Bulletin: Creative Biolabs Announces Breakthrough in Programmable In-Situ Cancer Vaccine Platforms

  • by

Creative Biolabs, a leading global provider of immunotherapy solutions, has introduced a specialized technical framework for developing next-generation in-situ vaccines. Shirley, New York, United States, April 10, 2026 — The platform focuses on engineering cancer… Read More »Technical Bulletin: Creative Biolabs Announces Breakthrough in Programmable In-Situ Cancer Vaccine Platforms